Servicio de Endocrinología y Nutrición, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Spain; Servicio de Endocrinología y Nutrición, ICMDM, Hospital Clínic de Barcelona, Barcelona, Spain.
Servicio de Endocrinología y Nutrición, ICMDM, Hospital Clínic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Facultad de Medicina, Universidad de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Endocrinol Diabetes Nutr (Engl Ed). 2021 Apr;68(4):260-269. doi: 10.1016/j.endien.2020.08.013. Epub 2021 Jul 8.
Familial non-medullary thyroid cancer is defined as the presence of non-medullary thyroid cancer in two or more first-degree relatives, in the absence of other predisposing factors. It represents up to 9% of differentiated thyroid cancers, and only a minority appears in well-known hereditary syndromes that associate thyroid cancer among many other clinical manifestations. However, in more than 95% of cases, thyroid cancer appears isolated, and its genetic causes have yet to be elucidated. We review here the current knowledge of the genetic basis of this pathology, as well as its clinical characteristics. Understanding the genetic mechanisms implied would help to comprehend the metabolic pathways involved, with the consequent potential therapeutic application. In addition, it would allow genetic counseling and to focus our efforts on patients at risk of developing this disorder.
家族性非髓样甲状腺癌定义为在没有其他易感因素的情况下,两个或多个一级亲属中存在非髓样甲状腺癌。它占分化型甲状腺癌的 9%,只有少数出现在众所周知的遗传性综合征中,这些综合征在许多其他临床表现中都伴有甲状腺癌。然而,在超过 95%的情况下,甲状腺癌是孤立出现的,其遗传原因尚未阐明。在这里,我们回顾了该病理学的遗传基础及其临床特征的现有知识。了解所涉及的遗传机制将有助于我们理解相关的代谢途径,从而带来潜在的治疗应用。此外,它还将允许进行遗传咨询,并将我们的努力集中在有发展这种疾病风险的患者身上。